Results 111 to 120 of about 20,763 (194)

Pseudomyxoma Peritonei: Role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction

, 2009
Guillaume Passot, Olivier Gléhen, Olivier Pellet, S. Isaac, Christelle Tychyj, Faheez Mohamed, Francesco Giammarile, François Noël Gilly, Eddy Cotte   +8 more
openalex   +2 more sources

Combined Mucinous and Neuroendocrine Tumours of the Appendix Managed with Surgical Cytoreduction and Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy [PDF]

, 2019
Roy Hajjar, Pierre Dubé, Andrew Mitchell, Lucas Sidéris   +3 more
openalex   +1 more source

58 Multidisciplinary surgical approach to increase complete cytoreduction rates for advanced ovarian cancer in a tertiary gynaecological oncology centre [PDF]

, 2020
Karen Mulligan, Kate Glennon, Fionán Donohoe, Yvonne O’Brien, R Mc Donnell, Helena C. Bartels, Carolien K. M. Vermeulen, Tom Walsh, Conor Shields, Orla Mc Cormack, John B. Conneely, William Boyd, Ruaidhri Mcvey, Jürgen Mulsow, Donal J. Brennan   +14 more
openalex   +1 more source

Transplantation tolerance, microchimerism, and the two-way paradigm [PDF]

, 1998
Demetris, AJ, Starzl, TE
core   +1 more source

Survival of patients with 2014 FIGO stage IIIC high-grade serous ovarian cancer who were treated with platin-based adjuvant chemotherapy. [PDF]

Turk J Med Sci
Ünsal M, Yücesoy M, Oktar O, Uçar Y, Güner GT, Aytekin O, Tokalioğlu AA, Yildirim HEK, Kiliç F, Ersak B, Çakir C, Yüksel D, Kiliç Ç, Koç S, Cömert GK, Tekin ÖM, Üstün YE, Turan T.   +17 more
europepmc   +1 more source

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer

, 2010
Marcello Deraco, Dario Baratti, Barbara Laterza, Maria Rosaria Balestra, Elvira Mingrone, Antonio Macrì, Salvatore Virzì, F Puccio, Paola Simona Ravenda, Shigeki Kusamura   +9 more
openalex   +2 more sources

Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome—over a decade of follow-up [PDF]

, 2019
Lynsey Daniels, Marian Khalili, William F. Morano, Michaela Simoncini, Beth Mapow, Andrea Leaf, Wilbur B. Bowne   +6 more
openalex   +1 more source

557 Peritoneal cancer index (PCI) as a predictor of completeness of cytoreduction at primary and interval debulking surgery in advanced ovarian cancer [PDF]

, 2020
Paula Fagan, Susana Banerjee, Desmond P.J. Barton, Angela George, Thomas Ind, Marielle Nobbenhuis, John Butler   +6 more
openalex   +1 more source

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis [PDF]

, 2016

core   +1 more source

Enhancing Prognosis in Advanced Ovarian Cancer: Primary Cytoreductive Surgery and Adjuvant Chemotherapy or Neoadjuvant Chemotherapy and Interval Cytoreduction-A Single-Center Retrospective Observational Study. [PDF]

Cancers (Basel)
Gheorghe AS, Chirea IA, Margan MM, Georgescu MT, Komporaly IA, Kajanto LA, Iovănescu EA, Georgescu B, Matei R, Zob DL, Mardare M, Ginghină O, Mihai MM, Stănculeanu DL.   +13 more
europepmc   +1 more source